According to a new market research report published by iHealthcareAnalyst, Inc., Cord Blood Banking Services Market – Global Therapeutic Applications Analysis and Forecast 2017-2021, the global cord blood banking services market is estimated to reach US$ 27.2 Billion in 2020, expanding at a CAGR of 5.3% from 2017 to 2021.
Visit the Cord Blood Banking Services Market – Global Therapeutic Applications Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/cord-blood-banking-services-market/
Cord blood banking facilities stores umbilical cord blood for future use in response to the potential for cord blood in treating diseases of the blood and immune systems. Both private and public cord blood banks have developed. Cord blood stem cells are blood cell progenitors which can form red blood cells, white blood cells, and platelets and are currently used to treat blood and immune system related genetic diseases, cancers, and blood disorders. The global cord blood banking services market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market based on type of therapy (standard therapy for leukemia, lymphoma, blood-related disorders and metabolic diseases; and stem cell therapy for autoimmune and cardiovascular disorders, diabetes, etc.), and by ownership type (public and private) and forecasts growth trends (CAGR% – 2017 to 2021). It also analyses the major companies operating in the global market.
The global cord blood banking services market is segmented as:
- Ownership Type
- Private Banks
- Public Banks
- Therapy Type
- Standard Therapy
- Blood Cell Proliferative Disorders
- Transplants for Inherited Diseases Affecting Immune System and Related Organs
- Transplants for Inherited Metabolic Conditions
- Stem Cells Therapy (Diabetes Mellitus, Cardiovascular, Auto-Immune Diseases, etc.)
- Standard Therapy
- Geography (Region, Country)
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Rest of LA)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Company Profiles
- China Cord Blood Corporation
- Cord Blood America, Inc.
- Cord Blood Registry Systems, Inc.
- Cordlife Group Ltd.
- Cryo-Cell International, Inc.
- Cryo-Save Group AV
- NeoStem, Inc.
- ViaCord, Inc.
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.